Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

08:56
10/10/16
10/10
08:56
10/10/16
08:56

Mylan gaps up sharply in pre-market after reaching deal with DOJ

The shares are up over 12% to $40.29 at time of writing. At that price next resistance is at $41.37. Support is at $39.20.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.

TODAY'S FREE FLY STORIES

DL

China Distance Education

$12.34

0.62 (5.29%)

09:02
12/08/16
12/08
09:02
12/08/16
09:02
Hot Stocks
China Distance Education revises share issuance plan on China's New Third Board »

China Distance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$74.67

0.81 (1.10%)

09:01
12/08/16
12/08
09:01
12/08/16
09:01
Hot Stocks
Duke Energy Renewables acquires Colorado solar project »

Duke Energy Renewables…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$154.30

4.45 (2.97%)

08:59
12/08/16
12/08
08:59
12/08/16
08:59
Recommendations
Valmont analyst commentary  »

Valmont facing multiple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

REXR

Rexford Industrial

$22.41

0.41 (1.86%)

08:57
12/08/16
12/08
08:57
12/08/16
08:57
Hot Stocks
Rexford Industrial acquires industrial property for $24.4M, sells two for $19M »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

lululemon

$59.84

2.6 (4.54%)

, HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

08:56
12/08/16
12/08
08:56
12/08/16
08:56
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS:…

LULU

lululemon

$59.84

2.6 (4.54%)

HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

AMD

AMD

$9.56

0.11 (1.16%)

TLRD

Tailored Brands

$18.93

0.62 (3.39%)

CTRV

ContraVir Pharmaceuticals

$1.99

-0.01 (-0.50%)

AVXL

Anavex

$3.73

-0.1 (-2.61%)

HRB

H&R Block

$23.34

0.65 (2.86%)

VYGR

Voyager Therapeutics

$13.73

-0.27 (-1.93%)

CMTL

Comtech

$12.75

0.77 (6.43%)

VRNT

Verint

$38.30

0.1 (0.26%)

VNCE

Vince Holding

$4.55

0.35 (8.33%)

CASY

Casey's General Stores

$124.22

1.14 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 08

    Dec

  • 14

    Dec

  • 09

    Jan

F

Ford

$13.06

0.5 (3.98%)

, BAC

Bank of America

$22.57

0.41 (1.85%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Options
Notable open interest changes for December 8th »

Wednesday's total…

F

Ford

$13.06

0.5 (3.98%)

BAC

Bank of America

$22.57

0.41 (1.85%)

AAPL

Apple

$111.03

1.08 (0.98%)

WFC

Wells Fargo

$57.28

1.73 (3.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 05

    Jan

  • 10

    Jan

  • 13

    Jan

  • 13

    Mar

08:55
12/08/16
12/08
08:55
12/08/16
08:55
General news
FX Action: The dollar »

FX Action: The dollar…

BHI

Baker Hughes

$66.14

-0.75 (-1.12%)

08:55
12/08/16
12/08
08:55
12/08/16
08:55
Conference/Events
Baker Hughes to hold an investor meeting »

Investor Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:54
12/08/16
12/08
08:54
12/08/16
08:54
Hot Stocks
Ciena sees Q1 adjusted gross margin in mid-40's percentage range »

Sees Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CIEN

Ciena

$21.60

0.6 (2.86%)

08:51
12/08/16
12/08
08:51
12/08/16
08:51
Hot Stocks
Ciena sees FY17 revenue growth faster than the market »

FY17 consensus $2.8B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AAPL

Apple

$111.03

1.08 (0.98%)

08:50
12/08/16
12/08
08:50
12/08/16
08:50
Periodicals
Apple, Goldwind partner to supply clean energy in China, SCMP reports »

Wind power turbine maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

08:50
12/08/16
12/08
08:50
12/08/16
08:50
General news
The 10k initial claims drop to 258k »

The 10k initial claims…

DRAM

Dataram

$1.27

0.07 (5.83%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Hot Stocks
Dataram acquisition targt U.S. Gold Corp. expands claims in Nevada »

Dataram's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCAP

Jernigan Capital

$20.21

-0.05 (-0.25%)

08:48
12/08/16
12/08
08:48
12/08/16
08:48
Syndicate
Jernigan Capital 2.65M share Spot Secondary priced at $19.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$DJT

DJ Transportation Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHIP

Seanergy Marine

$2.20

-0.1 (-4.35%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Syndicate
Seanergy Marine raises $15M in common stock and warrant offering »

Seanergy Marine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$53.50

-1.51 (-2.75%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Hot Stocks
Radius Health presents RAD1901 Phase 1 data at SABCS »

Radius Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DJX

Dow Jones Industrial Average

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$168.84

4.1 (2.49%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$48.18

0.9 (1.90%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$75.95

0.6 (0.80%)

08:47
12/08/16
12/08
08:47
12/08/16
08:47
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$84.12

1.6 (1.94%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$111.36

-15.01 (-11.88%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Recommendations
Universal Health analyst commentary  »

Universal Health selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

XLB

S&P Select Materials SPDR

$51.15

0.72 (1.43%)

08:46
12/08/16
12/08
08:46
12/08/16
08:46
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.